Type Private Website www.pathway.com Founded 2008 | Industry Biotechnology Founder James Plante | |
Headquarters San Diego, California, United States Profiles | ||
Welcome to pathway genomics
Pathway Genomics is a privately held global precision medical diagnostic company with mobile applications designed to empower physicians and their patients to take control of their health and wellness. Based in San Diego, California, the company offers genetic testing to physicians for their patients to support treatment a variety of health conditions. The test menu ranges from somatic and hereditary cancer, including BRCA1 and BRCA2, to pharmacogenomics testing for well-known drugs like Plavix, codeine, lamotrigine, to general health and wellness testing which includes information on a number of health conditions including type 1 and type 2 diabetes and hypertension.
Contents
- Welcome to pathway genomics
- Introduction to pathway genomics and genetic testing
- History
- IBM Partnership
- Products
- Executives
- Board of Directors
- References
Pathway Genomics owns and operates a clinical laboratory accredited by the College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) which “provides physicians and their patients with actionable and accurate precision healthcare information to improve or maintain, health and wellness in more than 40 different countries.”
Introduction to pathway genomics and genetic testing
History
The company was founded with the vision to make “genetic testing and personalized medicine accessible and affordable to everyone.” Pathway Genomics’ testing services cover a variety of conditions including somatic & hereditary cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response.
In addition to continual testing improvements and new testing developments, Pathway Genomics is also currently developing OME™. OME is the “world’s only mobile healthcare consumer application with artificial intelligence to help provide consumers with personalized health and wellness information.
IBM Partnership
In 2014, IBM Watson Group announced its partnership with Pathway Genomics, to help “deliver the first-ever cognitive consumer-facing app based on genetics from a user’s personal makeup.” The mobile app, subsequently named OME, is the first of its kind to merge artificial intelligence and deep learning, powered by IBM Watson, with personal genetic information. It provides users with personalized health and wellness information based on the individual’s health history.
Products
General Health & Wellness
Tests in this category analyze a variety of genomic markers selected to give patients and providers a better understanding of a patient’s risk for a number of health conditions. These tests help individuals to better understand their genetic propensity to specific diets, eating behaviors, nutritional needs, exercise activity and various health conditions, which is important for true, long-term, overall health and success in weight management.
Pharmacogenomics
Pharmacogenomic testing provides physicians with information about how their patient’s body responds to commonly prescribed pain, mental health, and cardiac-related medications.
Liquid Biopsy
The CancerIntercept™ tests are 96-mutation panels designed for the detection of somatic mutations in a set of 9 driver genes involved primarily in breast, ovarian, lung, and colorectal cancers, and melanoma. These tests, which must be ordered by a physician, may be used to either monitor patients already diagnosed with cancer or potentially detect undiagnosed cancer. Results are available within 2–3 weeks.
Hereditary Cancer Tests
Hereditary cancer testing is offered to patients with a personal and/or family history suggestive of cancer. These testing options include targeted panels, full gene panels, and a number of reflexive testing options.
Carrier Screening
Carrier DNA Insight® is a comprehensive preconception and prenatal carrier screening test. Carrier DNA Insight® follows the American College of Obstetricians and Gynecologists (ACOG) recommendations, and screen patients for more than 70 recessive genetic diseases. Carrier DNA Insight® provides physicians with information about the risks of inherited diseases of their patients’ future children.
Executives
Pathway Genomics’ executives include James Plante (Founder and CEO), Kamal Adawi (Chief Financial Officer), Michael Nova, M.D. (Chief Innovation Officer), K’Lene Oen (Chief Business Officer), Anthony Facinelli (Executive Vice President, Domestic Sales), Anja Kammesheidt, Ph.D. (Chief Scientific Officer), Nilesh Dharajiya, M.D. (Chief Laboratory Officer & Medical Director), Glenn D. Braunstein, M.D. (Chief Medical Officer), Michael H. Cox, CIPP (Chief Privacy and Compliance Officer), and Mitch Mulanix (Vice President of Business Development and Government Relations).
Board of Directors
Pathway Genomics’ Board of Directors include the sixteenth Chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace, Mark W. Sopp, Chris Kitching, and James Plante.